Unison Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
CWP
DADC
WG
Unison Advisors's PFE Position: Q2 2026 in Review
Unison Advisors increased its Pfizer (PFE) stake by 1.6% in Q2 2026, buying an estimated $40.6K and bringing the position to 98,488 shares worth $2.37M. The position accounts for 0.17% of the portfolio, ranked #69.
Unison Advisors first reported a position in PFE in Q2 2021 and has held it in 21 quarters since. The position peaked at $4.57M in Q4 2021. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Unison Advisors held 98,488 shares of Pfizer worth $2.37M as of Q2 2026.
- Unison Advisors bought 1,554 Pfizer shares in Q2 2026, an estimated $40.6K.
- Pfizer made up 0.17% of Unison Advisors's portfolio in Q2 2026, its #69 holding.
- Unison Advisors first reported a position in Pfizer in Q2 2021 and has held it in 21 quarters since.
- Unison Advisors's Pfizer position peaked at $4.57M in Q4 2021.
- 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Unison Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.